Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (Medicine), FRCP (Edin) UK, FRCP (Ireland)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (Medicine), FRCP (Edin) UK, FRCP (Ireland)
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology), MACG (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Gastroenterologist
MBBS, FCPS (Gastroenterology), FCPS (Medicine)
General Physician
MBBS, Diploma American Board Internal Medicine
Gastroenterologist
M.B.B.S, F.C.P.S.
Family Physician
M.B.B.S., Postgraduate Diploma in Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures